Duchesnay Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Duchesnay Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10896
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Duchesnay Inc (Duchesnay) is a pharmaceutical company that offers medications for use in pregnancy. The company’s products include diclectin, an antinauseant drug used for the management of nausea and vomiting; pregvit, a supplement that allow attaining nutrient levels of folic acid, iron, and calcium; and proctofoam-HC, a mucoadhesive analgesic and anti-inflammatory foam for the relief of anorectal inflammation and swelling. It also provides ladysystem, a feminine therapy to treat urinary stress incontinence caused by pelvic floor weakening; and mictoryl indicated for symptomatic treatment of urinary incontinence or increased urinary frequency and urgency in patients with overactive bladder. The company markets pharmaceutical products and medical devices in a variety of therapeutic areas, including obstetrics and gynecology, proctology, urology, and bacterial vaginosis. Duchesnay is headquartered in Blainville, Quebec, Canada.

Duchesnay Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Duchesnay Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Duchesnay Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Duchesnay Enters Into Distribution Agreement With Tzamal Medical For Diclectin Drug 10
Licensing Agreements 11
Duchesnay Receives Rights for Osphena from Shionogi 11
Alliance Pharma Enters into Licensing Agreement with Duchesnay for Diclectin 12
Duchesnay Inc – Key Competitors 13
Duchesnay Inc – Key Employees 14
Duchesnay Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Product News 16
07/06/2018: Alliance Pharma Marketing Authorisation for Diclectin in the UK 16
06/25/2018: Actress, Mom and Singer Jana Kramer is Expecting and Again Partnering with Duchesnay USA to Spread the Word about Bonjesta (doxylamine succinate – pyridoxine hydrochloride) 17
04/02/2018: Duchesnay USA Announces Availability of Bonjesta (doxylamine succinate – pyridoxine hydrochloride) in the United States 18
Product Approvals 19
Jun 07, 2018: Alliance Pharma Announces Positive Opinion for Diclectin 19
Jul 28, 2017: Alliance Pharma announce Update on Diclectin 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Duchesnay Inc, Pharmaceuticals & Healthcare, Key Facts 2
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Duchesnay Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Duchesnay Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Duchesnay Enters Into Distribution Agreement With Tzamal Medical For Diclectin Drug 10
Duchesnay Receives Rights for Osphena from Shionogi 11
Alliance Pharma Enters into Licensing Agreement with Duchesnay for Diclectin 12
Duchesnay Inc, Key Competitors 13
Duchesnay Inc, Key Employees 14
Duchesnay Inc, Subsidiaries 15

List of Figures
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Duchesnay Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • APEIRON Biologics AG:製薬・医療:M&Aディール及び事業提携情報
    Summary APEIRON Biologics AG (APEIRON) is a clinical-stage biotechnology company that concentrates on the development of biological and immunological solutions for the treatment of various cancers. The company’s pipeline products include APN01, APN301, APN311, APN401, APN411, APN421 and APN431. Its …
  • CESC Limited (CESC):企業の財務・戦略的SWOT分析
    CESC Limited (CESC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • GoldStone Resources Ltd (GRL):企業の財務・戦略的SWOT分析
    Summary GoldStone Resources Ltd (GoldStone) is a mining and mineral exploration company. The company acquires, explores, develops and produces gold properties. It offers exploration projects such as Homase-Akrokeri permits, Manso Amenfi permits, Sangola permits, Oyem permits and Ngoutou permits, amo …
  • Southwest Airlines Co:企業の戦略・SWOT・財務情報
    Southwest Airlines Co - Strategy, SWOT and Corporate Finance Report Summary Southwest Airlines Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Global Investment House KPSC (GLOBAL):企業の財務・戦略的SWOT分析
    Global Investment House KPSC (GLOBAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • STRATA Skin Sciences Inc (SSKN):企業の財務・戦略的SWOT分析
    STRATA Skin Sciences Inc (SSKN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Paratek Pharmaceuticals Inc (PRTK):企業の財務・戦略的SWOT分析
    Paratek Pharmaceuticals Inc (PRTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Baker IDI Heart and Diabetes Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Baker IDI Heart and Diabetes Institute (Baker Institute) is a medical research organization that offers diagnosis, prevention, treatment of diabetics and cardiovascular disease. The organization offers clinical services such as diabetes services, weight assessment and management clinic healt …
  • NUERNBERGER Beteiligungs-Aktiengesellschaft:企業の戦略・SWOT・財務情報
    NUERNBERGER Beteiligungs-Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report Summary NUERNBERGER Beteiligungs-Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Histogen Inc:医療機器:M&Aディール及び事業提携情報
    Summary Histogen Inc (Histogen) is a regenerative medicine company that develops novel therapies based on the products of cells grown under simulated embryonic conditions. The company’s products include a soluble multipotent cell conditioned media and insoluble extracellular matrix. Its products are …
  • Oaktree Capital Group Llc
    Oaktree Capital Group Llc - Strategy, SWOT and Corporate Finance Report Summary Oaktree Capital Group Llc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Lepu Medical Technology (Beijing) Co Ltd (300003)-医療機器分野:企業M&A・提携分析
    Summary Lepu Medical Technology (Beijing) Co Ltd (Lepu Medical) is a medical device company that designs, develops, and distributes medical equipments. The company’s products include interventional cardiology products, cardiac in vitro diagnosis products, occlusion devices, pacemaker, angiographic e …
  • Rev1 Ventures Inc.:企業のM&A・事業提携・投資動向
    Rev1 Ventures Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rev1 Ventures Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Xtant Medical Holdings Inc (XTNT):製薬・医療:M&Aディール及び事業提携情報
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowr …
  • Smerud Medical Research International AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Smerud Medical Research International AS (Smerud Medical) is a contract research organization that offers drug development services. The company conducts clinical trials to the pharmaceutical and biotechnology companies for improving new medical compounds. It provides services such as clinic …
  • Balfour Beatty plc:企業の戦略・SWOT・財務分析
    Balfour Beatty plc - Strategy, SWOT and Corporate Finance Report Summary Balfour Beatty plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Allergan Plc (AGN)-製薬・医療分野:企業M&A・提携分析
    Summary Allergan Plc (Allergan) is a specialty pharmaceutical company that develops and sells branded pharmaceuticals, biosimilar and over-the-counter (OTC) pharmaceutical products. It offers products in the areas of eye care, medical aesthetics, dermatology, central nervous system, gastroenterology …
  • Xellia Pharmaceuticals ApS:製薬・医療:M&Aディール及び事業提携情報
    Summary Xellia Pharmaceuticals ApS (Xellia), a subsidiary of Novo A/S is a healthcare products provider that offers fermented and semi-synthetic APIs and injectable finished dosage forms. The company offers strain and fermentation development with bacteria and fungi. It provides injectable products …
  • Afianzadora Latinoamericana Cia de Seguros S.A.:企業の戦略・SWOT・財務情報
    Afianzadora Latinoamericana Cia de Seguros S.A. - Strategy, SWOT and Corporate Finance Report Summary Afianzadora Latinoamericana Cia de Seguros S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Alon USA Energy, Inc.:企業の戦略・SWOT・財務情報
    Alon USA Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alon USA Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆